Tissue injury leads to the release of uric acid (UA). At high local concentrations, UA can form monosodium urate crystals (MSU). MSU and UA stimulate neutrophils to release extracellular traps (NET). Here, we investigated whether these NET could be involved in the development of inflammation by stimulating cytokine release by airway epithelial cells. We found that NET significantly increased the secretion of CXCL8/IL-8 and IL-6 by alveolar and bronchial epithelial cells. These effects were not observed when NETosis was inhibited by Diphenyleneiodonium, elastase inhibitor, or Cl-amidine. Similar findings were made with NET induced by cigarette smoke extract, suggesting that NET proinflammatory capacity is independent of the inducing stimulus. Furthermore, NET affected neither the viability and morphology of epithelial cells nor the barrier integrity of polarized cells. The epithelial stimulatory capacity of NET was not affected by degradation of DNA with micrococcal nuclease, treatment with heparin, or inhibition of the elastase immobilized to DNA, but it was significantly reduced by pretreatment with an anti-HMGB-1 blocking antibody. Altogether, our findings indicate that NET exert direct proinflammatory effects on airway epithelial cells that might contribute in vivo to the further recruitment of neutrophils and the perpetuation of inflammation upon lung tissue damage.

Journal Section:
Editor's choice
Keywords:
Neutrophil extracellular traps, Monosodium urate crystals, Uric acid, Cigarette smoke, Human epithelial cells
1.
Bals R, Hiemstra PS: Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 2004;23:327-333.
2.
Parker D, Prince A: Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol 2011;45:189-201.
3.
Rossaint J, Zarbock A: Tissue-specific neutrophil recruitment into the lung, liver, and kidney. J Innate Immun 2013;5:348-357.
4.
Kolaczkowska E, Kubes P: Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013;13:159-175.
5.
Pittman K, Kubes P: Damage-associated molecular patterns control neutrophil recruitment. J Innate Immun 2013;5:315-323.
6.
Gasse P, Riteau N, Charron S, Girre S, Fick L, Pétrilli V, et al: Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med 2009;179:903-913.
7.
Matthay MA, Ware LB, Zimmerman GA: The acute respiratory distress syndrome. J Clin Invest 2012;122:2731-2740.
8.
Abraham E: Neutrophils and acute lung injury. Crit Care Med 2003;31:S195-S199.
9.
Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, et al: Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 2009;5:e1000639.
10.
Mitroulis I, Kambas K, Chrysanthopoulou A, Skendros P, Apostolidou E, Kourtzelis I, et al: Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout. PLoS One 2011;6:e29318.
11.
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al: Neutrophil extracellular traps kill bacteria. Science 2004;303:1532-1535.
12.
Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A: Neutrophil function: from mechanisms to disease. Annu Rev Immunol 2012;30:459-489.
13.
Cui B-B, Tan C-Y, Schorn C, Tang H-H, Liu Y, Zhao Y: Neutrophil extracellular traps in sterile inflammation: the story after dying? Autoimmunity 2012;45:593-596.
14.
Kaplan MJ, Radic M: Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol 2012;189:2689-2695.
15.
Dworski R, Simon HU, Hoskins A, Yousefi S: Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol 2011;127:1260-1266.
16.
Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew A-A, et al: Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 2011;179:199-210.
17.
Dwyer M, Shan Q, D'Ortona S, Maurer R, Mitchell R, Olesen H, et al: Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor. J Innate Immun 2014;6:765-779.
18.
Manzenreiter R, Kienberger F, Marcos V, Schilcher K, Krautgartner WD, Obermayer A, et al: Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. J Cyst Fibros 2012;11:84-92.
19.
Thomas GM, Carbo C, Curtis BR, Martinod K, Mazo IB, Schatzberg D, et al: Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 2012;119:6335-6343.
20.
Rock KL, Kataoka H, Lai J-J: Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 2013;9:13-23.
21.
Kono H, Chen C-J, Ontiveros F, Rock KL: Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 2010;120:1939-1949.
22.
Kataoka H, Yang K, Rock KL: The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung. Eur J Pharmacol 2015;746:174-179.
23.
Kuipers MT, Aslami H, Vlaar APJ, Juffermans NP, Tuip-de Boer AM, Hegeman MA, et al: Pre-treatment with allopurinol or uricase attenuates barrier dysfunction but not inflammation during murine ventilator-induced lung injury. PLoS One 2012;7:e50559.
24.
Brusselle GG, Joos GF, Bracke KR: New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011;378:1015-1026.
25.
Schiltz C, Lioté F, Prudhommeaux F, Meunier A, Champy R, Callebert J, et al: Monosodium urate monohydrate crystal-induced inflammation in vivo: quantitative histomorphometric analysis of cellular events. Arthritis Rheum 2002;46:1643-1650.
26.
Higashi T, Mai Y, Noya Y, Horinouchi T, Terada K, Hoshi A, et al: A simple and rapid method for standard preparation of gas phase extract of cigarette smoke. PLoS One 2014;9:e107856.
27.
Gabelloni Ml, Sabbione F, Jancic C, Fuxman Bass J, Keitelman I, Iula L, et al: NADPH oxidase-derived reactive oxygen species are involved in human neutrophil IL-1β secretion but not in inflammasome activation. Eur J Immunol 2013;43:3324-3335.
28.
Colado A, Almejún MB, Podaza E, Risnik D, Stanganelli C, Elías EE, et al: The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients. Cancer Immunol Immunother 2017;66:461-473.
29.
Martínez D, Vermeulen M, von Euw E, Sabatté J, Maggíni J, Ceballos A, et al: Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12. J Immunol 2007;179:1950-1959.
30.
Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G: A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976;17:62-70.
31.
Bayer H, Müller T, Myrtek D, Sorichter S, Ziegenhagen M, Norgauer J, et al: Serotoninergic receptors on human airway epithelial cells. Am J Respir Cell Mol Biol 2007;36:85-93.
32.
Amstad P, Reddel RR, Pfeifer A, Malan-Shibley L, Mark GE, Harris CC: Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral Harvey ras. Mol Carcinog 1988;1:151-160.
33.
Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, et al: CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Bio 1994;10:38-47.
34.
Kono H, Orlowski GM, Patel Z, Rock KL: The IL-1-dependent sterile inflammatory response has a substantial caspase-1-independent component that requires cathepsin C. J Immunol 2012;189:3734-3740.
35.
Schorn C, Janko C, Krenn V, Zhao Y, Munoz LE, Schett G, et al: Bonding the foe - NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals. Front Immunol 2012;3:376.
36.
Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A: Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 2010;191:677-691.
37.
Arai Y, Nishinaka Y, Arai T, Morita M, Mizugishi K, Adachi S, et al: Uric acid induces NADPH oxidase-independent neutrophil extracellular trap formation. Biochem Biophys Res Commun 2014;443:556-561.
38.
Chrysanthopoulou A, Mitroulis I, Apostolidou E, Arelaki S, Mikroulis D, Konstantinidis T, et al: Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol 2014;233:294-307.
39.
Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, et al: Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009;184:205-213.
40.
Wu T-T, Chen T-L, Loon W-S, Tai Y-T, Cherng Y-G, Chen R-M: Lipopolysaccharide stimulates syntheses of toll-like receptor 2 and surfactant protein-A in human alveolar epithelial A549 cells through upregulating phosphorylation of MEK1 and ERK1/2 and sequential activation of NF-κB. Cytokine 2011;55:40-47.
41.
Greene CM, McElvaney NG: Toll-like receptor expression and function in airway epithelial cells. Arch Immunol Ther Exp (Warsz) 2005;53:418-427.
42.
Kondo Y, Higa-Nakamine S, Noguchi N, Maeda N, Toku S, Isohama Y, et al: Induction of epithelial-mesenchymal transition by flagellin in cultured lung epithelial cells. AJP Lung Cell Mol Physiol 2012;1057-1069.
43.
Ferrero MC, Fossati CA, Baldi PC: Direct and monocyte-induced innate immune response of human lung epithelial cells to Brucella abortus infection. Microbes Infect 2010;12:736-747.
44.
Grässle S, Huck V, Pappelbaum KI, Gorzelanny C, Aponte-Santamaría C, Baldauf C, et al: Von Willebrand factor directly interacts with DNA from neutrophil extracellular traps. Arterioscler Thromb Vasc Biol 2014;34:1382-1389.
45.
Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, et al: Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010;107:15880-15885.
46.
Walsh DE, Greene CM, Carroll TP, Taggart CC, Gallagher PM, O'Neill SJ, et al: Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium. J Biol Chem 2001;276:35494-35499.
47.
Andersson U, Tracey KJ: HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011;29:139-162.
48.
He M, Kubo H, Ishizawa K, Hegab AE, Yamamoto Y, Yamamoto H, et al: The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007;293:L1427-L1436.
49.
Katsuoka F, Kawakami Y, Arai T, Imuta H, Fujiwara M, Kanma H, et al: Type II alveolar epithelial cells in lung express receptor for advanced glycation end products (RAGE) gene. Biochem Biophys Res Commun 1997;238:512-516.
50.
Chow AWM, Ko WH, Liang JFT, Wong JSC, Fu Y, Tang NLS: Polarized secretion of interleukin (IL)-6 and IL-8 by human airway epithelia 16HBE14o- cells in response to cationic polypeptide challenge. PLoS One 2010;5:e12091.
51.
Sun Y, Wu F, Sun F, Huang P: Adenosine promotes IL-6 release in airway epithelia. J Immunol 2008;180:4173-4181.
52.
Barrientos L, Bignon A, Gueguen C, Chaisemartin D, Gorges R, Sandré C, et al: Neutrophil extracellular traps downregulate lipopolysaccharide-induced activation of monocyte-derived dendritic cells. J Immunol 2014;193:5689-5698.
53.
Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Galuska SP, Lohmeyer J, et al: Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012;7: e32366.
54.
Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-241.
55.
Gasse P, Riteau N, Vacher R, Michel M-L, Fautrel A, di Padova F, et al: IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS One 2011;6:e23185.
56.
Abraham E, Carmody A, Shenkar R, Arcaroli J: Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000;279:L1137-L1145.
57.
Yildiz C, Palaniyar N, Otulakowski G, Khan MA, Post M, Kuebler WM, et al: Mechanical ventilation induces neutrophil extracellular trap formation. Anesthesiology 2015;122:864-875.
58.
Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, et al: HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004;5:825-830.
59.
Marcos V, Zhou Z, Yildirim AÖO, Bohla A, Hector A, Vitkov L, et al: CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med 2010;16:899.
60.
Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, et al: Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas aeruginosa pneumonia in cystic fibrosis. Mol Med 2012;18:477-485.
61.
Chirico V, Lacquaniti A, Leonardi S, Grasso L, Rotolo N, Romano C, et al: Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection 2015;1:1-9.
62.
Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL: Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990;87:9188-9192.
63.
Ratjen F, Paul K, Van Koningsbruggen S, Breitenstein S, Rietschel E, Nikolaizik W: DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha. Pediatr Pulmonol 2005;39:1-4.
64.
Ratjen F, Grasemann H: New therapies in cystic fibrosis. Curr Pharm Des 2012;18:614-627.
65.
Cheng OZ, Palaniyar N: NET balancing: a problem in inflammatory lung diseases. Front Immunol 2013;4:1.
© 2017 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2017
You do not currently have access to this content.